艾伯维(ABBV)股价与投研分析

AbbVie · 美国市场 · 医药健康

关键指标

最新价
USD 294.83
日内涨跌
+3.09%
市值
USD 5209.99 亿
市盈率 TTM
50.66
市净率
-113.70
52 周最高
USD 298.74
52 周最低
USD 190.75
股息率
2.35%
成交量
股 843.51 万
上市市场
美国

公司概况

艾伯维(英文名 AbbVie,股票代码 ABBV)在美国市场上市, 属于医药健康行业,当前处于成熟阶段。核心标签:制药、修美乐、高股息。

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

AI 三层投研框架

  1. 宏观周期层:利率、通胀、汇率与流动性如何影响美国市场的估值中枢。
  2. 行业格局层:用 PEST、波特五力与产业链位置判断医药健康行业的利润分配。
  3. 公司质地层:把 艾伯维 的增速、利润率、ROE 与现金流放进同行业横向对比。

需要完整报告?回到终端 可基于真实财报数据生成三层 AI 分析。

同市场公司

医药健康行业公司